SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is surging following a massive short squeeze and positive sentiment surrounding a high-profile White House meeting with industry leaders. Community members are debating if this marks the definitive end of the bear market as investors rotate capital back into crypto assets.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are surging as positive Phase 3 trial results for its mRNA-based cancer vaccine, developed in partnership with Merck, trigger a massive short squeeze that has drawn significant retail and institutional interest. While investors are debating the long-term commercial impact of the personalized treatment and potential for future share dilution, the community remains intensely divided between those celebrating a breakthrough in oncology and those warning of a potential pullback from current valuation levels.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors speculate on a potential take-private bid from Nelson Peltz's Trian Fund Management, leading to intense debate among community members regarding the stock's valuation and the possibility of a short squeeze. Long-term bulls are aggressively holding their positions and urging others to buy the float, while skeptics and short sellers remain active, questioning the credibility of the buyout rumors and the company's long-term financial health.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as it hits new 52-week highs, driven by strong institutional accumulation and positive momentum following record revenue growth. The community is actively discussing the stock's breakout potential as it challenges critical resistance levels, while many investors highlight the company's strong commercial position as a primary catalyst for long-term growth.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing elevated trading activity as investors react to a significant earnings announcement scheduled for after the bell, with the community actively debating whether the stock is poised for a short squeeze or another post-earnings sell-off. Sentiment remains deeply divided between those betting on a macro trend reversal and others concerned about historical patterns of volatility and institutional manipulation within the fintech sector.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending as investors weigh strong earnings and long-term revenue growth guidance against insider selling sentiment, all while tracking its strategic pivot into precision oncology via the Personalis acquisition. The stock remains a focal point for intense community debate, with bulls citing its unique healthcare data moat and potential for a short squeeze, while bears highlight persistent volatility and integration concerns.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is seeing increased attention as traders react to a wave of short liquidations across the broader crypto market, sparking widespread community debate on whether a new bull cycle has truly begun. Many investors are closely tracking institutional accumulation patterns and upcoming regulatory discussions while debating the asset's potential for a significant breakout above recent resistance levels.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is currently under selling pressure as market participants react to a mix of negative technical momentum and concerns over a potential decline in consumer spending. Traders are actively debating whether the recent dip represents a buying opportunity for a long-term defensive play or if further downside is likely following the breach of key technical support levels.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining attention as investors eagerly anticipate clinical trial data, with the community actively speculating on the potential for a major partnership or buyout. The discourse focuses on the company's dual-agonist efficacy, comparing its therapeutic profile against established market leaders and monitoring institutional sentiment ahead of upcoming industry conferences.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors react to a Q2 earnings report that beat analyst expectations and raised revenue guidance, while the company continues to highlight its Matrix-M adjuvant's integration into upcoming oncology and combination vaccine pipelines. Community sentiment remains polarized, with many shareholders expressing frustration over stagnant price action and management's communication style, while others maintain conviction in the long-term value of its partnerships with major pharmaceutical players.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Oils-Energy Stocks Lagging  PattersonUTI Energy (PTEN) This Year?

Here is how Patterson-UTI (PTEN) and SunCoke Energy (SXC) have performed compared to their sector so far this year.

Are Investors Undervaluing SunCoke Energy (SXC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SunCoke Energy (SXC) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

SunCoke Energy, Inc. Q2 2026 Earnings Call Summary

SunCoke Energy, Inc. Q2 2026 Earnings Call Summary...

SunCoke Energy (SXC) Tops Q2 Earnings and Revenue Estimates

SunCoke (SXC) delivered earnings and revenue surprises of +87.50% and +9.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

SunCoke Energy Inc. Reveals Climb In Q2 Income

(RTTNews) - SunCoke Energy Inc. (SXC) reported a profit for its second quarter that Increased, from the same period last year...

SunCoke Energy, Inc. Reports Second Quarter 2026 Results

SunCoke Energy, Inc. (NYSE: SXC) today reported results for the second quarter 2026, reflecting strong operational and financial performance. "Our second quarter results reflect very strong operating performance from our Industrial Services and Domestic Coke businesses," said Katherine Gates...

SunCoke Energy, Inc. Declares Cash Dividend

Today, SunCoke Energy, Inc. (NYSE: SXC) announced that its Board of Directors declared a cash dividend of $0.12 per share of the Companys common stock to be paid on September 2, 2026 to stockholders of record at the close of business on August 17, 2026.ABOUT SUNCOKE ENERGY, INC.SunCoke Energy, Inc...

SunCoke Energy, Inc. Announces Second Quarter 2026 Earnings Date

SunCoke Energy, Inc. (NYSE: SXC) plans to release its second quarter 2026 financial results on Thursday, July 30, 2026, before trading opens on the New York Stock Exchange. SXC will host its quarterly earnings call at 11:00 am ET on July 30, 2026. The conference call will be webcast live at...

SunCoke Energy Q1 Earnings Call Highlights

SunCoke Energy (NYSE:SXC) reported first-quarter 2026 results that management said reflected strong operational execution, despite weather-related disruptions at its coke plants and a turbine issue...

$SXC Q2 '26 Earnings Results & Recap

SunCoke Energy, Inc. is increasing its full-year 2026 Consolidated Adjusted EBITDA guidance range to between $250 million and $265 million, while projecting net income to be between $23 million and $42 million.

SunCoke Energy, Inc. engages in the production of coke through the heating of metallurgical coal in refractory ovens. It operates through the Domestic Coke, Brazil Coke, and Logistics segments. The Domestic Coke segment consists of coke making facilities and heat recovery operations at the Jewell, Indiana Harbor, Haverhill, Granite City, and Middletown plants. The Brazil Coke segment focuses on operations in Vitória, Brazil. The Logistics segment includes the CMT facilities located in the U.S. Gulf Coast and the U.S. East Coast. The company was founded in 1960 and is headquartered in Lisle, IL.

SunCoke Energy Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SXCSunCoke Energy Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SXC News